Vera Therapeutics: Funding, Investors & Team (Sep 2026)
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. The company's gene-editing technology can potentially cure patients with sickle cell disease, cystic fibrosis, and other devastating genetic disorders, enabling physicians to improve gene detection and regulation.
Vera Therapeutics has raised $826M across 5 funding rounds on record, the most recent an undisclosed round of $261M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vera Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Vera Therapeutics Funding Rounds
Vera Therapeutics raised $74.9M in a Post-IPO Equity announced in Feb 2022.
1 years later, an undisclosed round of $115M was announced in Feb 2023.
1.7 years later, an undisclosed round of $300M was announced in Oct 2024.
8 months later, an undisclosed round of $75.0M was announced in Jun 2025.
6 months later, an undisclosed round of $261M was announced in Dec 2025.
Vera Therapeutics Founders and Leadership Team
Contact details for the Vera Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Vera Therapeutics Funding Compared to Other Biotechnology Startups
Vera Therapeutics' latest round of $261M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vera Therapeutics in Biotechnology and South San Francisco
Companies Similar to Vera Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Vera Therapeutics Funding FAQs
What does Vera Therapeutics do?
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. The company's gene-editing technology can potentially cure patients with sickle cell disease, cystic fibrosis, and other devastating genetic disorders, enabling physicians to improve gene detection and regulation.
How much funding has Vera Therapeutics raised?
Vera Therapeutics has raised $826M across 5 rounds on record. The most recent is an undisclosed round of $261M announced in Dec 2025.
When did Vera Therapeutics last raise funding?
Vera Therapeutics' most recent funding round on record is an undisclosed round of $261M, announced in Dec 2025.
Who founded Vera Therapeutics?
FundedIQ lists Marshall Fordyce (Founder) at Vera Therapeutics.
Where is Vera Therapeutics headquartered?
Vera Therapeutics is based in South San Francisco, California, United States.
How many employees does Vera Therapeutics have?
Vera Therapeutics is in the 11-50 employee band.
How does Vera Therapeutics' funding compare to other Biotechnology startups?
Vera Therapeutics' latest round of $261M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Vera Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vera Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.